PSA levels and ageing: what does testosterone actually tell us?

The interpretation of a PSA level, or Prostate-Specific Antigen, is not always straightforward and can leave men with unanswered questions. A value below 4.0 ng/ml is generally considered normal, but this is not an absolute rule. Factors such as age, ethnicity and the use of certain medications can significantly influence this threshold, meaning that a “normal” value for one man may differ from that of another. This variability makes it difficult to draw conclusions without in-depth knowledge, often leading to unnecessary concern or, conversely, a false sense of reassurance. Many men who take a proactive interest in their health encounter this complexity, which only increases the need for clear, reliable guidance on prostate health.

You may now be wondering what role testosterone plays in this complex interplay of prostate health and PSA levels, and how you can ensure an accurate interpretation of these indicators. It is important to understand that testosterone, while essential for many bodily functions, has a dual role when it comes to the prostate. An excess may contribute to prostate growth, while testosterone supplementation, such as with TRT, can initially cause a rise in PSA levels. The interaction between testosterone and prostate health is complex, and having the right insight into this relationship is invaluable. Discover how to interpret your body’s signals correctly, what influence testosterone truly has, and how to avoid unnecessary anxiety about your PSA levels.

What is a normal PSA level for men?

The normal PSA level in men is a topic that often raises questions, especially when you are looking into your prostate health or testosterone optimisation. In general, a PSA level below 4.0 ng/ml is considered normal, although this is not an absolute threshold. It is important to understand that this value can vary due to several factors, such as your age, ethnicity, and any medication you may be using. A slightly elevated value does not automatically mean that there is a serious condition, but it is a signal to investigate further and monitor the situation—particularly if you have concerns about your health.

Reference values for PSA levels by age group.

Interpreting your PSA level requires a careful approach, because a value that is considered normal at one stage of life may be regarded as abnormal at another. For example, in men between the ages of 40 and 49, a PSA level of up to 2.5 ng/ml is often considered normal, while for men aged 70 and older, a value of up to 6.5 ng/ml may still fall within acceptable limits. These age-related reference values are important for a proper assessment and help prevent unnecessary concern, allowing you to look at your health with greater confidence.

How does testosterone affect the prostate?

Testosterone, a crucial hormone for male health, plays a complex role in the prostate. It is essential for the normal growth and function of this gland, but an excess or imbalance may potentially contribute to prostate enlargement, known as benign prostatic hyperplasia (BPH). Prostate cells contain enzymes that convert testosterone into dihydrotestosterone (DHT), a much more potent androgen. This DHT then stimulates the growth of prostate tissue. For this reason, careful monitoring of hormone level, particularly during testosterone therapy, is very important to safeguard prostate health and minimise potential risks. This includes regular check-ups and blood tests.

5-alpha reductase stimulates cell division through DHT.

The relationship between testosterone and prostate cancer is also the subject of extensive research. Historically, it was believed that testosterone stimulated prostate cancer, but more recent studies suggest a more nuanced picture, in which the role of testosterone in the initiation of prostate cancer is less direct than previously assumed. However, in the presence of existing prostate cancer, testosterone can indeed influence the growth of cancer cells. This makes it essential that, if you are considering starting testosterone therapy, a thorough medical assessment and regular follow-up, including measuring PSA levels, take place. This helps actively monitor your prostate health and detect any unwanted developments at an early stage, so that your healthcare provider can intervene appropriately if necessary.

Why does a PSA level rise during therapy?

When you start testosterone replacement therapy (TRT), it is normal for your Prostate-Specific Antigen (PSA) level to increase slightly at first. This rise is usually a result of the increased testosterone levels stimulating prostate activity, which leads to a higher production of PSA. It is a physiological response that does not directly indicate an underlying prostate problem, but rather reflects the normalisation of hormonal balance. This initial increase is carefully monitored by IKARIA Clinics to ensure that the rise remains within safe and expected limits, and to detect any potential abnormalities at an early stage.

Stabilisation of PSA after 6-12 months of TRT

The rise in PSA levels at the start of TRT is a well-documented phenomenon, and understanding this is important to prevent unnecessary concern. After the initial peak, which typically occurs within the first 3 to 6 months, PSA levels often stabilise at a new, slightly higher level. This new level then becomes the reference point for future measurements. IKARIA Clinics closely monitors your PSA levels and compares them with your baseline value before treatment. This allows for a complete overview of prostate health during therapy and helps identify any potential abnormalities at an early stage.

What are the risks of a low value?

Although the focus is often on elevated PSA levels and their possible implications, it is important to understand that a PSA level that is too low can also carry certain risks, particularly in the context of screening and diagnosis. You might assume that a low value is always a good sign, but this is not necessarily the case. An artificially low PSA level can make it more difficult to detect prostate problems, including prostate cancer. This means you may develop a false sense of reassurance, while something may still be going on beneath the surface. It is therefore important to understand the context of a low PSA level, especially if you are using certain medications that can affect PSA production.

5-alpha reductase inhibitors can halve PSA value

One of the main risks of an extremely low PSA level is that it can give a distorted picture of your prostate health. Certain medications, such as 5-alpha reductase inhibitors, can significantly lower your PSA level—sometimes by as much as 50%. This can effectively mask a rise that might otherwise indicate prostate cancer. As a result, an important diagnosis may be missed or delayed, which can negatively affect treatment options and prognosis. It is therefore very important to inform your doctor about all medications you are taking so that PSA results can be interpreted correctly. A low value is not always reassuring; in some cases, it may actually be a warning sign that screening is incomplete.

Can supplementation cause the prostate to grow?

No, testosterone supplementation, also known as testosterone replacement therapy (TRT), does not cause the prostate to grow abnormally or increase the risk of prostate cancer. This is a common misconception that originates from outdated beliefs. Extensive scientific research has shown that testosterone, when maintained within physiological levels, does not have a direct effect on the growth of prostate cells. You therefore do not need to worry about this when choosing testosterone optimisation at IKARIA Clinics, as we always work in accordance with the most up-to-date medical insights and guidelines.

How can you recognise prostate problems early?

Recognising prostate symptoms at an early stage is crucial for effective treatment and for maintaining your overall health. Early signs can be subtle, but they should not be ignored. For example, pay attention to changes in your urinary pattern, such as needing to urinate more often, especially at night, a weaker urine stream, or the feeling that your bladder is not completely empty after urinating. These symptoms may indicate an enlarged prostate, also known as benign prostatic hyperplasia (BPH), which is common in men over the age of 40. It is important to take these changes seriously and not wait too long, as the earlier you take action, the better the outlook.

Blood in urine or semen: an important warning symptom

In addition to urinary symptoms, there are other indicators that may point to prostate problems. Pain or a burning sensation when urinating, blood in the urine or semen, or persistent pain in the lower back, hips, or pelvis are warning signs that require immediate medical attention. Although these symptoms do not always indicate a serious condition, such as prostate cancer, it is essential to obtain an accurate diagnosis. By being proactive and consulting a specialist at the first signs of discomfort, any potential problems can be detected and treated at an early stage, significantly improving your chances of a full recovery.

Which factors influence the PSA measurement?

The reliability of a PSA test, an important indicator of prostate health, can be influenced by several factors. Age, for example, plays a role, as the prostate naturally becomes larger with ageing, which can increase PSA levels. Inflammation or infections of the prostate, known as prostatitis, can also lead to temporarily elevated PSA levels. These inflammatory processes cause a reaction in the tissue, which stimulates the release of PSA into the bloodstream. As a result, the measurement may be less accurate if these factors are not taken into account.

Is hormone therapy safe for the prostate?

Hormone therapy, specifically testosterone replacement therapy (TRT), often raises questions about its safety for the prostate, particularly due to the historical misconception that testosterone stimulates prostate cancer. However, recent scientific research has largely dispelled this concern. Studies show that testosterone is not a direct cause of prostate cancer and does not significantly accelerate the growth of an already existing, undetected tumour. On the contrary, very low testosterone levels have even been associated with more aggressive forms of prostate cancer, highlighting the importance of a balanced hormonal system.

Scientific literature is largely reassuring about TRT

When you are considering testosterone therapy, a thorough initial screening of the prostate is essential. This includes a digital rectal examination and a blood test for Prostate-Specific Antigen (PSA). An elevated PSA level may indicate prostate issues, including an enlarged prostate or, in rarer cases, prostate cancer. If these values fall within the normal range, TRT can be started safely. During the therapy, IKARIA Clinics will monitor your PSA levels regularly, typically every 3 to 6 months during the first year, to detect any changes early and respond appropriately.

When is a high PSA level dangerous?

An elevated PSA level on its own is not a direct indication of prostate cancer, but it is an important marker that may warrant further investigation. The level of concern depends on several factors, including the absolute PSA value, how quickly it is rising, and the ratio between free and total PSA. A PSA level above 4.0 ng/mL is generally considered elevated and requires attention, although this can also occur in cases of benign prostate enlargement or inflammation. It is important to understand that a single measurement is rarely sufficient to make a definitive diagnosis. For this reason, IKARIA Clinics always takes a holistic approach when assessing prostate health.

A lower ‘free PSA / total PSA’ ratio increases risk.

In addition to the absolute value, PSA velocity—the increase in PSA levels over a certain period—is an indicator of potential risk. A rapid rise, for example more than 0.75 ng/mL per year, may suggest a more aggressive condition and requires immediate medical evaluation. Furthermore, the ratio between free and total PSA plays a significant role. A lower free PSA / total PSA ratio, for example below 10–15%, significantly increases the risk of prostate cancer. This means that when PSA levels are elevated, it is important to look beyond the numerical value alone and consider all available diagnostic information.

How often is medical monitoring necessary?

When you start testosterone replacement therapy (TRT), an initial medical check-up is essential to establish your baseline values and determine whether this therapy is suitable for you. This assessment includes comprehensive blood tests, including the Prostate-Specific Antigen (PSA) level, as well as a physical examination. This helps identify any underlying conditions before treatment begins. It is then important to undergo a follow-up check after 3 to 6 months, as this is the period during which your body adapts to the hormone therapy. During this time, the dosage may need to be adjusted to achieve optimal results and minimise potential side effects.

These early check-ups are very important for a safe and effective start to the treatment, with your wellbeing always being the top priority.

PSA monitoring: at the start of TRT, after 3–6 months, and annually thereafter

After the initial adjustment period, an annual medical check-up is usually sufficient to monitor your health and ensure the effectiveness of testosterone replacement therapy. During these yearly check-ups, blood tests are repeated — including the PSA level — to detect any changes in your hormone levels and prostate health at an early stage. In addition, the doctor will discuss your overall wellbeing and address any symptoms or concerns you may have. This regular monitoring is not only important for maintaining optimal health, but also for identifying any potential risks associated with long-term hormone therapy at an early stage. In this way, IKARIA Clinics ensures that you receive the best possible care throughout your entire treatment journey, with a strong focus on prevention and proactive adjustments where needed.

Conclusion PSA

You now have a deeper understanding of the complex relationship between PSA levels, prostate health, and testosterone. PSA is more than just a number; it is a dynamic indicator influenced by many factors such as age, ethnicity, and medication. A value below 4.0 ng/ml is often considered normal, but this is not a universal threshold. You have also learned that testosterone is essential for the prostate, and that although an excess may contribute to prostate enlargement, testosterone supplementation within physiological ranges does not increase the risk of prostate cancer. Even a PSA level that is too low can be problematic, as it may make it more difficult to detect prostate issues.

Especially during testosterone replacement therapy (TRT), careful monitoring is essential, as a slight initial increase in PSA levels can be expected, after which they usually stabilise. All of this highlights that a holistic approach to prostate health is indispensable. You deserve to feel your best and to manage your health proactively.

However, this information is not a substitute for professional medical advice. If you have concerns about your PSA levels, prostate health, or are considering testosterone therapy, it is essential to consult a qualified specialist. A detailed assessment of your personal situation is necessary to establish the correct diagnosis and the most effective treatment plan. Take the step towards a healthier life today, contact IKARIA Clinics for a personal consultation.